Paced QRS duration is not just an ECG observation — it is a surrogate for how physiologically the ventricle is being activated, and a predictor of who will develop pacing-induced cardiomyopathy.
Every paced beat on a 12-lead ECG tells a story about where the impulse originates and how it spreads. In patients with conventional right ventricular (RV) apical or septal leads, that story typically reads as a wide, LBBB-like complex measuring 150 to 180 ms. In patients paced from the left bundle branch area (LBBAP), the story is very different: a narrower complex, often under 130 ms, with preserved terminal forces. That difference is not cosmetic. It reflects two fundamentally different modes of ventricular activation, with measurable consequences for mechanics, remodeling, and long-term outcomes.
The His-Purkinje system exists for a reason. It delivers the depolarization wavefront to millions of ventricular myocytes nearly simultaneously, producing coordinated contraction and the characteristic narrow native QRS of 80 to 110 ms. When an RV pacing lead captures working myocardium at the apex or mid-septum, this network is bypassed. The impulse must then spread cell-to-cell through gap junctions at roughly 0.3 to 0.5 m/s — an order of magnitude slower than Purkinje conduction. The result is a prolonged, discoordinated activation sequence: the paced ventricle depolarizes early, the free wall lags, and the terminal portions of the QRS stretch far beyond the physiologic range.
Conduction system pacing reverses this. When the lead captures the left bundle or its proximal fascicles, the native His-Purkinje network is recruited almost immediately. Left ventricular activation proceeds through its intended high-speed tracts, and septal-to-lateral timing is preserved. The paced QRS narrows correspondingly, and the V6 R-wave peak time — a practical LBBAP confirmation marker — falls within 75 to 85 ms.
Paced QRS width is the simplest bedside surrogate for activation physiology. Wider implies slower, cell-to-cell spread. Narrower implies Purkinje recruitment. Everything downstream — mechanics, remodeling, and outcomes — flows from that distinction.
Electrical dyssynchrony begets mechanical dyssynchrony. In RV-paced hearts, the septum contracts early against a relatively relaxed lateral wall, which then contracts late against an already-relaxing septum. This septal-lateral delay wastes mechanical energy, reduces stroke work efficiency, and loads the mitral apparatus abnormally. Over months to years, the LV responds with eccentric remodeling: increased end-diastolic volume, thinned walls, functional mitral regurgitation, and eventually a drop in ejection fraction.
This cascade is the pathophysiologic core of pacing-induced cardiomyopathy (PICM), generally defined as an absolute EF decline of ≥10% to a value below 50% in a patient with significant RV pacing burden. The key modifiable variables are pacing burden and paced QRS width — and of these, QRS width is the one that conduction system pacing can directly change.
| Parameter | RV Apical / Septal Pacing | Left Bundle Branch Area Pacing |
|---|---|---|
| Typical paced QRS | 150–180 ms | 110–130 ms |
| Morphology | LBBB-like, wide terminal forces | RBBB-like, preserved terminal forces |
| Activation pathway | Myocardial cell-to-cell | His-Purkinje recruitment |
| Septal-lateral delay | Substantial | Minimal |
| PICM risk (high burden) | Elevated | Significantly reduced |
| LVEF trajectory | Declining in vulnerable patients | Preserved or improved |
Multiple contemporary studies and registries reinforce the narrow-QRS-equals-better-outcomes relationship. LBBP-RESYNC demonstrated superior echocardiographic response and LVEF improvement with LBBAP compared with biventricular CRT in heart failure patients with LBBB. The MELOS registry, one of the largest LBBAP cohorts to date, confirmed the feasibility, safety, and stable electrical parameters of the technique across thousands of implants. Earlier work from the His-SYNC family of trials, comparing His bundle pacing to biventricular CRT, established the general principle that physiologic pacing produces narrower QRS complexes and comparable or superior clinical response. Observational PICM literature — including data from patients with preserved EF at baseline who later developed cardiomyopathy after prolonged RV pacing — consistently identifies paced QRS duration as an independent predictor.
In patients who already have wide-QRS heart failure, cardiac resynchronization therapy (CRT) aims to shorten the QRS as a direct electrical endpoint. QRS narrowing post-implant correlates with echocardiographic response, reverse remodeling, and survival. LBBAP and LOT-CRT (LBBAP-optimized CRT, combining an LV coronary sinus lead with an LBBAP lead) extend this logic: if narrow QRS is the goal, capture the conduction system directly.
For the patient with a leadless or transvenous RV system and a high pacing burden, these principles translate into a concrete surveillance and decision framework:
Narrower paced QRS ≈ more physiologic activation ≈ preserved LV mechanics ≈ lower PICM and heart failure risk. The argument for conduction system pacing — and for upgrading vulnerable RV-paced patients to LBBAP before overt dysfunction — rests on that chain of inference.
It reflects more physiologic ventricular activation through the His-Purkinje system rather than slow cell-to-cell myocardial spread. This preserves LV mechanical synchrony, reduces eccentric remodeling, and lowers PICM risk — especially in patients with high RV pacing burden.
A paced QRS under 130 to 140 ms is generally favorable; under 120 ms is ideal and typically only achievable with conduction system pacing (LBBAP or His bundle pacing). RV apical pacing usually produces 150 to 180 ms.
Yes. Wide paced QRS combined with high RV pacing burden (generally above 20 to 40%) is the classic substrate for PICM. Multiple studies show paced QRS duration is an independent predictor of PICM and LV dysfunction.
By capturing the left bundle or its proximal fascicles, LBBAP recruits the native His-Purkinje network. This restores near-simultaneous LV activation and preserves septal-to-lateral timing, yielding a significantly narrower paced QRS than RV apical pacing.
No — but patients with high RV pacing burden plus structural, functional, or biomarker evidence of adverse remodeling deserve formal LBBAP upgrade evaluation before EF declines below 50%. Early intervention preserves the window for prevention rather than rescue.